Brief: EQL Pharma: Mellozzan Approved For Sale In Kazakhstan
15/07/2026 08:59
BRIEF-EQL Pharma: Mellozzan Approved For Sale In Kazakhstan July 15 (Reuters) - EQL Pharma AB EQL.ST:
MELLOZZAN® (MELATONIN) APPROVED IN KAZAKHSTAN
MELLOZZAN APPROVED FOR SALE IN KAZAKHSTAN
MELLOZZAN LAUNCH OF BOTH STRENGTHS EXPECTED IN FY 2027/28
Source text: ID:nWkr2vFjzw
Further company coverage: EQL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))